Literature DB >> 9103241

MCP-1-mediated chemotaxis requires activation of non-overlapping signal transduction pathways.

H Yen1, Y Zhang, S Penfold, B J Rollins.   

Abstract

Monocyte chemoattractant protein-1 (MCP-1) is a CC chemokine that attracts monocytes and T lymphocytes. Its receptor (CCR2) is a heptahelical G-protein-coupled receptor (GPCR) whose signal transduction pathways for chemotaxis have not been completely defined. Because other GPCRs stimulate the mitogen-activated protein kinase (MAPK) cascade, we examined this pathway's activity in response to MCP-1. MCP-1 induced rapid and transient activation of MAPK in human monocytes and in Chinese hamster ovary cells expressing CCR2B. This effect was largely insensitive to pertussis toxin and wortmannin, and was protein kinase C-dependent and protein tyrosine kinase-independent. PD 098059, an inhibitor of MEK activation, not only prevented MAPK activation but also inhibited MCP-1-induced chemotaxis. Because pertussis toxin and wortmannin also efficiently inhibit chemotaxis but do not completely inhibit MAPK activation, these data may define non-overlapping signal transduction pathways that all must be activated to produce chemokine-mediated chemotaxis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9103241     DOI: 10.1002/jlb.61.4.529

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  17 in total

1.  Leucocyte chemotaxis: Examination of mitogen-activated protein kinase and phosphoinositide 3-kinase activation by Monocyte Chemoattractant Proteins-1, -2, -3 and -4.

Authors:  J H Wain; J A Kirby; S Ali
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

2.  Evaluation of signal transduction pathways in chemoattractant-induced human monocyte chemotaxis.

Authors:  J S Fine; H D Byrnes; P J Zavodny; R W Hipkin
Journal:  Inflammation       Date:  2001-04       Impact factor: 4.092

3.  Frontline Science: Buprenorphine decreases CCL2-mediated migration of CD14+ CD16+ monocytes.

Authors:  Matias Jaureguiberry-Bravo; Lillie Lopez; Joan W Berman
Journal:  J Leukoc Biol       Date:  2018-05-23       Impact factor: 4.962

4.  The Angiotensin Receptor Blocker Losartan Suppresses Growth of Pulmonary Metastases via AT1R-Independent Inhibition of CCR2 Signaling and Monocyte Recruitment.

Authors:  Daniel P Regan; Jonathan W Coy; Kirti Kandhwal Chahal; Lyndah Chow; Jade N Kurihara; Amanda M Guth; Irina Kufareva; Steven W Dow
Journal:  J Immunol       Date:  2019-04-10       Impact factor: 5.422

5.  Real-time imaging reveals that P2Y2 and P2Y12 receptor agonists are not chemoattractants and macrophage chemotaxis to complement C5a is phosphatidylinositol 3-kinase (PI3K)- and p38 mitogen-activated protein kinase (MAPK)-independent.

Authors:  Katrin Isfort; Franziska Ebert; Julia Bornhorst; Sarah Sargin; Rozina Kardakaris; Manolis Pasparakis; Martin Bähler; Tanja Schwerdtle; Albrecht Schwab; Peter J Hanley
Journal:  J Biol Chem       Date:  2011-11-04       Impact factor: 5.157

Review 6.  Endothelin-2, the forgotten isoform: emerging role in the cardiovascular system, ovarian development, immunology and cancer.

Authors:  Lowell Ling; Janet J Maguire; Anthony P Davenport
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

7.  Metabolic products of soluble epoxide hydrolase are essential for monocyte chemotaxis to MCP-1 in vitro and in vivo.

Authors:  Suman Kundu; Talat Roome; Ashish Bhattacharjee; Kevin A Carnevale; Valentin P Yakubenko; Renliang Zhang; Sung Hee Hwang; Bruce D Hammock; Martha K Cathcart
Journal:  J Lipid Res       Date:  2012-11-15       Impact factor: 5.922

8.  Benzydamine inhibits monocyte migration and MAPK activation induced by chemotactic agonists.

Authors:  Elena Riboldi; Giada Frascaroli; Pietro Transidico; Walter Luini; Sergio Bernasconi; Francesca Mancini; Angelo Guglielmotti; Claudio Milanese; Mario Pinza; Silvano Sozzani; Alberto Mantovani
Journal:  Br J Pharmacol       Date:  2003-08-18       Impact factor: 8.739

9.  MCP-1-induced migration of NT2 neuroprogenitor cells involving APP signaling.

Authors:  Emmanuel George Vrotsos; Kiminobu Sugaya
Journal:  Cell Mol Neurobiol       Date:  2008-12-02       Impact factor: 5.046

Review 10.  Intimal hyperplasia in murine models.

Authors:  David Y Hui
Journal:  Curr Drug Targets       Date:  2008-03       Impact factor: 3.465

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.